维普中文期刊产品整合服务
28篇 您的检索式:作者名="Wikstrand C"
    题名 作者 年代 出处 被引量
1Dextran,gelatin,and hydroxyethyl starch do not affect permeability for albumin in cat skeletal muscle显示文摘Holbeck S Bentzer P Wikstrand C 2001Crit Care Med2001,29,1:1
2Human gliomamesenchymal extracellular matrix antigen defined by monoclonal antibody 显示文摘Bourdon MA Wikstrand C J Furthmayr H 1983Cancer Res1983,43,6:1
3High apoB/apoA -1 ratio is as- sociated with increased progression rate of earotid artery intima - media thickness in clinically healthy 58 - year - old men : experiences ti'om very long - term follow - up in the AIR study 显示文摘Schmidt C Wikstrand J 2009Atherosclerosis2009,205,1:1
4Dex- tran,gelatin, and hydroxyethyl starch do not affect permeability for albumin incat skeletal muscle 显示文摘HOLBECK S BENTZER P WIKSTRAND C 2001Crit Care Med2001,29,1:1
5HighapoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long- term foliowup in the AIR study显示文摘Schmidt C Wikstrand J 2009Atherosclerosis2009,205,1:1
6High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men:experiences from very long-term follow-up in the AIR study显示文摘Schmidt C Wikstrand J 2009Atherosclerosis2009,205,1:1
7Dextran, gelatin, and hydroxyethyl starch do not affect permeability for albumin in cat skeletal muscle 显示文摘 Bentzer P Wikstrand C 2001Crit Care Med2001,29,1:1
8C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake,smoking andatherosclerosis显示文摘Fagerberg B Behre C J Wikstrand J 0,,07:1
9Mouse/human chimeric Mel-14 antibody genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization 显示文摘Batra S K Niswonger M L Wikstrand C J 1994Hybridoma1994,13,:1
10Primary prevention in patients with hypertension:comments on the clinical implications of the MAPHY study metoprolol atherosclerosis prevention in hypertensives study 显示文摘Wikstrand J Warnold I Olsson C 1998Am Heart J1998,116,12:1
11Generation of antiidiotypic reagents in the EGFRV Ⅲ tumor associated antigen system显示文摘Wikstrand C J Cole V R Crotty L E 2002Cancer Immunother2002,50,12:1
12EGF mutant receptor v m as a molecular target in cancer therapy 显示文摘Kuan CT Wikstrand C J Bigner DD 2001Endocr Relat Cancer2001,8,2:1
13Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody显示文摘Bourdon MA Wikstrand C J Furthmayr H 1983Cancer Res1983,43,:1
14C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis 显示文摘Fagerberg B Beher C J Wikstrand J 2008Scand J Clin Lab Invest2008,68,7:1
15Epidermal Growth Factor Ligand-Independent, Unregulated, Cell-Transforming Potential of A Naturally Occurring Human Mutant EGFRv Ⅲ Gene 显示文摘Batra S K Castelino-Prabhu S Wikstrand C J 1995Cell Growth Differ1995,6,:1
16Monoclonal Antibodies Against Egfrviii are Tumor Specific and React with Breast and Lung Carcinomas and Malignant Gliomas 显示文摘Wikstrand C J Hale L P Batra S K 1995Cancer Res1995,55,:1
17High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 5g-year-old men : experiences from very long-term follow-up in the AIR study 显示文摘Schmidt C Wikstrand J 2009Atherosclerosis2009,205,:1
18High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long-term follow-up in the AIR study显示文摘Schmidt C Wikstrand J 2009Atherosclerosis2009,205,1:1
19EGFRvⅢ as a promising target for antibody-based brain tumor therapy显示文摘KUAN C T WIKSTRAND C J BIGNER D D 2000Brain Tumor Pathol2000,17,2:1
20Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutanl EGFRv Ⅲ gene 显示文摘Batra SK Castelino-Prabhu S Wikstrand C J 1995Cell Growth Differ1995,6,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费